Shimadzu and Frontier Lab provide a new versatile tool for the comprehensive analysis of polymer samples. It consists of Shimadzu's GCMS-QP2010 quadrupole series and Frontier Lab's new Multi-Shot EGA/PY-3030D vertical micro furnace pyrolyzer.
Shimadzu and Frontier Lab provide a new versatile tool for the comprehensive analysis of polymer samples. It consists of Shimadzu’s GCMS-QP2010 quadrupole series and Frontier Lab’s new Multi-Shot EGA/PY-3030D vertical micro furnace pyrolyzer. Both companies have teamed up in Pyrolysis-GCMS for years.
The PY-3030D is equipped with a low thermal mass ceramic heater featuring improved thermal stability and an extended temperature range from ambient + 10 °C to1050 °C. This enables the analysis of temperature-sensitive compounds as well as the cracking of highly temperature-stable polymers using high-temperature pyrolysis. The low mass ceramic heater and the new design of the pyrolysis/GC interface contribute to increased heating and cooling rates, leading to higher productivity because of very short heater cycle times.
Optimized temperature control ensures increased reproducibility of pyrolysis data, particularly at higher temperatures. In addition, the outstanding performance of the GCMS-QP2010 series contributes to the excellent reproducibility of the data.
The wide range of new accessories opens up new potentials for the analysis of polymers – a configuration is available for nearly every analytical challenge. The sample introduction systems offer increased application possibilities including the analysis of weathering products and reactions at high pressure. By simply changing the sampler, different sample introduction methods such as single-shot/double-shot pyrolysis, liquid injection, reactive pyrolysis or sample irradiation with UV light can be selected.
For further details please visit www.shimadzu.eu
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.